◆ NeutralJNJ
J&J CEO Now Sees 'Line of Sight' to Double-Digit Growth for His $100 Billion Company. Here's Why Investors Should Pay Attention.
The Motley Fool·
Johnson & Johnson's CEO Joaquin Duato projects double-digit growth for the $100 billion healthcare company, supported by 28 platforms generating $1 billion each in revenue. The company plans to invest $55 billion in the U.S. over four years, including a new biologics manufacturing facility in North Carolina, leveraging favorable tax policies to drive growth in cancer, immune-mediated, and neurological disease treatments.
Read Full Article at The Motley Fool →